BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 199024)

  • 1. [Lipoprotein metabolism in cholestasis].
    Patsch W
    Acta Med Austriaca Suppl; 1977; (4):86-7. PubMed ID: 199024
    [No Abstract]   [Full Text] [Related]  

  • 2. Lipoprotein metabolism in liver disease.
    Green PH
    Lab Res Methods Biol Med; 1983; 7():199-204. PubMed ID: 6353105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic importance of lipoprotein-X (LP-X) in the diagnosis of cholestasis.
    Palynyczko Z; Milewski B
    Mater Med Pol; 1975; 7(4):327-33. PubMed ID: 175222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic secretion enzymes and electrophoretic lipoprotein fractions in liver disease.
    Tăpălagă D; Opincaru A; Cucuianu M
    Acta Hepatogastroenterol (Stuttg); 1979 Feb; 26(1):9-16. PubMed ID: 34311
    [No Abstract]   [Full Text] [Related]  

  • 5. Metabolism of plasma lipoproteins.
    Faergeman O
    Acta Med Scand Suppl; 1977; 614():1-29. PubMed ID: 206106
    [No Abstract]   [Full Text] [Related]  

  • 6. Lipoprotein abnormalities in cholestasis. I. Electrophoretic and ultracentrifugal analyses.
    Watanabe M
    Acta Med Okayama; 1979 Aug; 33(4):269-85. PubMed ID: 227230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apolipoprotein A-1 in cholestatic liver diseases.
    Yamamoto K; Koga S; Ibayashi H
    Clin Chim Acta; 1978 Jul; 87(1):85-92. PubMed ID: 208804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma cholesterol esterification in liver disease.
    Blomhoff JP
    Scand J Gastroenterol; 1976; 11(8):753-6. PubMed ID: 1006148
    [No Abstract]   [Full Text] [Related]  

  • 9. Plasma lecithin:cholesterol acyltransferase activity and the lipoprotein abnormalities of liver disease.
    Harry DS; Day RC; Owen JS; Agorastos J; Foo AY; McIntyre N
    Scand J Clin Lab Invest Suppl; 1978; 150():223-7. PubMed ID: 746353
    [No Abstract]   [Full Text] [Related]  

  • 10. A critical examination of the value of combined determinations of lecithin:cholesterol acyltransferase and lipoprotein-X in the differential diagnosis of liver disease.
    Miller JP; Johnson K
    Clin Chim Acta; 1976 May; 69(1):81-4. PubMed ID: 1269156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparative studies on lipoprotein changes after cholestasis in rats and humans].
    Klör U; Ditschuneit HH; Hotz J; Mico L; Ditschuneit H
    Med Welt; 1972 Oct; 23(41):1428-9. PubMed ID: 4343896
    [No Abstract]   [Full Text] [Related]  

  • 12. [Quantitative determination of apolipoprotein A in human serum by laser nephelometry].
    Girault A; Loiseau D; Girault M
    Ric Clin Lab; 1981; 11 Suppl 2():19-29. PubMed ID: 6798675
    [No Abstract]   [Full Text] [Related]  

  • 13. Studies on the degradation of lipoprotein-X.
    Patsch W; Patsch JR; Kunz F; Sailer S; Braunsteiner H
    Eur J Clin Invest; 1977 Dec; 7(6):523-30. PubMed ID: 204492
    [No Abstract]   [Full Text] [Related]  

  • 14. Lecithin:cholesterol acyl transfer rate in plasma and its relations to lipoprotein concentrations and to kinetics of bile acids and triglycerides in hyperlipoproteinemic subjects.
    Wallentin L; Angelin B; Einarsson K; Leijd B
    Scand J Clin Lab Invest Suppl; 1978; 150():103-10. PubMed ID: 218268
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of cholestyramine on lipoprotein metabolism in rat blood].
    Tvorogova MG; Titov VN; Sanfirova VM
    Farmakol Toksikol; 1982; 45(4):48-51. PubMed ID: 7128784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Lipoproteins, apolipoproteins, lipoprotein lipase, hepatic triglyceride lipase and lecithin cholesterol acyltransferase in patients with nephrotic syndrome].
    Breier C; Lisch HJ; Drexel H; Braunsteiner H
    Schweiz Med Wochenschr; 1983 Jun; 113(25):909-13. PubMed ID: 6612272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective effect of rutin on lipids, lipoproteins, lipid metabolizing enzymes and glycoproteins in streptozotocin-induced diabetic rats.
    Stanely Mainzen Prince P; Kannan NK
    J Pharm Pharmacol; 2006 Oct; 58(10):1373-83. PubMed ID: 17034661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipoprotein metabolism in liver disease.
    Sabesin SM; Bertram PD; Freeman MR
    Adv Intern Med; 1980; 25():117-46. PubMed ID: 6987838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid and lipoprotein abnormalities in liver disease: the possible role of lecithin: cholesterol acyltransferase deficiency.
    McIntyre N; Calandra S; Pearson AJ
    Scand J Clin Lab Invest Suppl; 1974; 137():115-20. PubMed ID: 4367610
    [No Abstract]   [Full Text] [Related]  

  • 20. Lipoproteins in plasma from patients with low LCAT activity due to biliary obstruction.
    Danielsson B; Ekman R; Johansson BG; Nilsson-Ehle P; Petersson BG
    Scand J Clin Lab Invest Suppl; 1978; 150():214-7. PubMed ID: 218276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.